📰 Nasdaq Pcvx News
Page 6 - Nasdaq Pcvx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Nasdaq Pcvx. Real-time updates on events, politics, business and more.
May 8, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating)’s stock price hit a new 52-week high on Monday . The stock traded as high as $51.88 and last traded at $51.48, with a volume of 43187 shares. The stock had previously closed at $51.40. Wall Street Analysts Forecast Growth Several analysts have recently weighed in on PCVX shares. […]
May 2, 2023
Shares of Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $49.44 and last traded at $48.61, with a volume of 103032 shares. The stock had previously closed at $48.26. Analyst Upgrades and Downgrades A number of equities analysts recently issued […]
May 1, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) was the target of a significant growth in short interest in April. As of April 15th, there was short interest totalling 7,050,000 shares, a growth of 17.3% from the March 31st total of 6,010,000 shares. Based on an average daily trading volume, of 870,900 shares, the days-to-cover ratio is […]
May 1, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) was up 4.8% on Monday . The company traded as high as $44.90 and last traded at $44.90. Approximately 94,858 shares were traded during trading, a decline of 89% from the average daily volume of 847,566 shares. The stock had previously closed at $42.83. Wall Street Analyst Weigh In […]
April 30, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) was the recipient of a large increase in short interest during the month of April. As of April 15th, there was short interest totalling 7,050,000 shares, an increase of 17.3% from the March 31st total of 6,010,000 shares. Based on an average trading volume of 870,900 shares, the days-to-cover […]
April 21, 2023
TD Cowen began coverage on shares of Vaxcyte (NASDAQ:PCVX – Get Rating) in a report issued on Tuesday morning, Briefing.com reports. The firm issued an outperform rating on the stock. A number of other research analysts also recently commented on the company. Needham & Company LLC restated a buy rating and set a $58.00 price […]
April 21, 2023
SAN CARLOS, Calif., April 21, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering...
April 17, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating)’s stock price gapped up before the market opened on Monday . The stock had previously closed at $36.50, but opened at $42.04. Vaxcyte shares last traded at $42.76, with a volume of 677,688 shares. Analysts Set New Price Targets A number of brokerages recently issued reports on PCVX. Guggenheim […]
April 16, 2023
SAN CARLOS, Calif., April 16, 2023 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering...
March 1, 2023
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) gapped down prior to trading on Tuesday after Guggenheim lowered their price target on the stock from $66.00 to $65.00. The stock had previously closed at $42.30, but opened at $40.00. Guggenheim currently has a buy rating on the stock. Vaxcyte shares last traded at $38.74, with a volume […]